Antibiotic resistance has become one of the most documented public health problems in India, and a significant driver is the prescription written before a clear bacterial cause is established. The World Health Organization has named India among the countries with the highest rates of antimicrobial resistance, and ICMR surveillance data consistently shows that common pathogens, Klebsiella, E. coli, Staphylococcus aureus, are losing susceptibility to first-line drugs at a measurable rate. The problem is not that doctors are careless. It is that the consultation is often short, the patient expects a prescription, and the questions that would change the outcome take time to ask.
Is this infection bacterial, viral, or something else entirely?
Most upper respiratory infections, the sore throat, the runny nose, the three-day fever that follows a cold, are viral. Antibiotics do nothing to a virus. The Indian Academy of Pediatrics and clinical guidelines from ICMR both note that the majority of acute respiratory tract infections in otherwise healthy patients resolve without antibiotics. The first question a careful clinician asks is whether the presentation even fits a bacterial picture: high fever persisting beyond five days, localised pain, purulent discharge, a patient who is deteriorating rather than plateauing. A viral infection typically peaks and begins to ease. A bacterial infection often does not. This question alone, asked honestly, eliminates a large share of unnecessary prescriptions.
![White Tablets and Dropper]()
White Tablets and Dropper
Image credit : AI
I examine these tablets, considering the importance of antibiotic stewardship India and when to take antibiotics.
Has enough time passed to watch and wait?
Watchful waiting, a defined period of observation before prescribing, is a formal strategy recommended by WHO for acute otitis media in older children and for uncomplicated lower urinary tract symptoms where the differential is not yet clear. In a busy Indian clinic, this is the hardest question to operationalise, because it requires a follow-up mechanism that many settings do not have. But the question still matters: has the patient been symptomatic for two days or ten? A two-day fever with no localising signs is a different clinical situation from a ten-day one. Time is diagnostic information, and skipping the question skips the information.
What does the patient's recent antibiotic history look like?
A patient who completed a course of amoxicillin three weeks ago for a chest infection and is now presenting again with similar symptoms is not a patient for whom the same drug is automatically the right answer. Repeated short courses select for resistant organisms in the individual patient's own flora. The question about recent antibiotic use, in the last month, in the last three months, changes the empirical choice if an antibiotic is genuinely indicated. It also sometimes reveals that the presenting symptoms are a consequence of the previous course rather than a new infection. This question is quick to ask and frequently skipped.
![Blank Page, Ready for Ideas]()
Blank Page, Ready for Ideas
Image credit : AI
A fresh page awaits. Considering when to take antibiotics is crucial for antibiotic stewardship.
Is a culture or a rapid diagnostic test feasible here?
India's diagnostic infrastructure is uneven, and this question has an honest answer that varies by setting. A rapid strep test costs under a hundred rupees at most urban pathology labs and takes fifteen minutes. A urine culture before treating a urinary tract infection is standard of care in guidelines from the Indian Association of Urological Surgeons for recurrent cases. The question is not whether every sore throat needs a culture, it does not, but whether the specific presentation, the specific patient, and the specific antibiotic being considered warrant one. Asking the question forces a decision rather than a default.
What is the narrowest drug that covers the likely pathogen?
Broad-spectrum antibiotics, third-generation cephalosporins, fluoroquinolones, carbapenems, are the drugs that resistance erodes fastest, because they exert the widest selection pressure on microbial communities. ICMR's national antibiotic stewardship guidelines explicitly recommend reserving these for cases where narrow-spectrum drugs have failed or where the pathogen is known to require them. The question of spectrum is one a patient can reasonably ask, not to second-guess the prescription, but to understand it: is there a narrower option that covers what you think this is? A clinician who has asked themselves this question will have an answer. One who has not may not. Antibiotic stewardship is not about refusing treatment when treatment is genuinely needed. It is about the five minutes of clinical reasoning that decides whether the drug on the slip is the right one, for the right organism, at the right moment. These questions are what that reasoning sounds like.